Cargando…

Avoidance of β-blockers in patients who use stimulants is not supported by good evidence

Detalles Bibliográficos
Autores principales:	Wilson, Tyler, Pitcher, Ian, Bach, Paxton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900778/ https://www.ncbi.nlm.nih.gov/pubmed/35101873 http://dx.doi.org/10.1503/cmaj.211347

Ejemplares similares

L’évitement des β-bloquants chez les patients qui utilisent des stimulants ne repose pas sur des données probantes
por: Wilson, Tyler, et al.
Publicado: (2022)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

β-blockers in septic shock: are we there yet?
por: Cruz, Madalena Coutinho, et al.
Publicado: (2017)

Who's Afraid of the Big Bad Wolf? Safety of Beta-Blockers in COPD
por: Ambrosio, Giuseppe, et al.
Publicado: (2019)

Commentary: Good things come to those who wait
por: Vo, Thin X., et al.
Publicado: (2021)

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Avoid clinical inertia: Importance of asking and advising patients with diabetes who smoke about quitting
por: Yatsuya, Hiroshi
Publicado: (2020)

Commentary: Use fusion to avoid confusion
por: DiNardo, James A.
Publicado: (2020)

CT score in COVID-19-related pneumonia, the radiologist, and the internist. Trying to unmask who is “the good”, who is “the bad” and who is “the ugly”
por: Crisci, Giulia, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence
por: Hennessy, Sean, et al.
Publicado: (2020)

Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence
por: Good, Chester B., et al.
Publicado: (2018)

Quality of care: how good is good enough?
por: Chassin, Mark R
Publicado: (2012)

Commentary: Good surgery gets good results: Not so good if your patient is anemic
por: Kramer, Robert S.
Publicado: (2021)

Vascular consequences of passive Aβ immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?
por: Barger, Steven W
Publicado: (2005)

Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
por: Fitzgerald, Paul J
Publicado: (2012)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Commentary: The enemy of good is perfect, but please define good and perfect
por: Worku, Berhane, et al.
Publicado: (2020)

Hyperinsulinemia-euglycemia therapy: a useful tool in treating calcium channel blocker poisoning
por: Levine, Michael D, et al.
Publicado: (2006)

Heart disease: recruitment of MEF2 activity by β−blockers wards off cardiomyocyte death
por: Hashemi, S, et al.
Publicado: (2015)

Extubation failure: an outcome to be avoided
por: Epstein, Scott K
Publicado: (2004)

Good and bad fever
por: Cavaillon, Jean-Marc
Publicado: (2012)

Prestin and the good vibrations
por: Birke, Anna Sofia, et al.
Publicado: (2016)

Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence
por: Turgeon, Ricky D., et al.
Publicado: (2020)

Evidence-based support for the use of proton pump inhibitors in cancer therapy
por: Fais, Stefano
Publicado: (2015)

Good Clinical Trials by removing defensive interpretation of Good Clinical Practice guidelines
por: den Heijer, Jonas M., et al.
Publicado: (2021)

Cancer immunotherapy: avoiding the road to perdition
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2004)

Debate: Albumin administration should not be avoided
por: Allison, Simon P, et al.
Publicado: (2000)

New Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant Hypertension
por: Narayan, Hafid, et al.
Publicado: (2016)

Prostaglandin I(2) Receptor Agonism for Proteinuria and Diabetes: Good for the Goose and Good for the Gander?
por: Menon, Madhav C., et al.
Publicado: (2016)

Angiotensin receptor blockers in heart failure after the ELITE II trial
por: Willenheimer, Ronnie
Publicado: (2000)

Can heterogeneity in ventilation be good?
por: Costa, Eduardo LV, et al.
Publicado: (2010)

good doctors for indian villages
por: Hegde, Belle M
Publicado: (2015)

Commentary: One is as good as three
por: Athanasuleas, Constantine L.
Publicado: (2021)

Commentary: It looks good, but will it last?
por: Eikelboom, Rachel, et al.
Publicado: (2020)

Might stimulant drugs support moral agency in ADHD children?
por: Hyman, Steven Edward
Publicado: (2013)

Avoiding risk at what cost? Putting use of medicines for breastfeeding women into perspective
por: Amir, Lisa H, et al.
Publicado: (2012)

Is assessment good for learning or learning good for assessment? A. Both? B. Neither? C. It depends?
por: Cilliers, Francois J
Publicado: (2015)

All It Takes for Corruption in Health Systems to Triumph, Is Good People Who Do Nothing: Comment on "We Need to Talk About Corruption in Health Systems"
por: Mostert, Saskia, et al.
Publicado: (2019)

Avoiding Pandemic Fears in the Subway and Conquering the Platypus
por: Gonzalez, A., et al.
Publicado: (2016)

Commentary: Keeping it simple to avoid going commando
por: Carroll, Nels D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1j5jd769rdsp0uio3e6l57otgc